This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1998 Apr-Jun;18(2 Suppl):S12-8.

doi: 10.1177/0272989X98018002S03.

Experimental versus observational data in the economic evaluation of pharmaceuticals

PMID: 9566462
DOI: 10.1177/0272989X98018002S03

Comparative Study

Experimental versus observational data in the economic evaluation of pharmaceuticals

M F Drummond. Med Decis Making. 1998 Apr-Jun.

. 1998 Apr-Jun;18(2 Suppl):S12-8.

doi: 10.1177/0272989X98018002S03.

Author

PMID: 9566462
DOI: 10.1177/0272989X98018002S03

No abstract available

PubMed Disclaimer

Similar articles

Economic evaluation of pharmaceuticals. Frankenstein's monster or vampire of trials?
O'Brien B. O'Brien B. Med Care. 1996 Dec;34(12 Suppl):DS99-108. Med Care. 1996. PMID: 8969318 Review. No abstract available.
Pharmacoeconomics.
Ahuja J, Gupta M, Gupta AK, Kohli K. Ahuja J, et al. Natl Med J India. 2004 Mar-Apr;17(2):80-3. Natl Med J India. 2004. PMID: 15141600 Review.
Economic evaluation of pharmaceuticals: science or marketing?
Drummond MF. Drummond MF. Pharmacoeconomics. 1992 Jan;1(1):8-13. doi: 10.2165/00019053-199201010-00004. Pharmacoeconomics. 1992. PMID: 10147035 No abstract available.
Evaluating the role of bias in pharmacoeconomic studies.
Joish VN. Joish VN. Manag Care Interface. 2001 Aug;14(8):57-60. Manag Care Interface. 2001. PMID: 11517839
Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
Barbieri M, Drummond M, Willke R, Chancellor J, Jolain B, Towse A. Barbieri M, et al. Value Health. 2005 Jan-Feb;8(1):10-23. doi: 10.1111/j.1524-4733.2005.03070.x. Value Health. 2005. PMID: 15841890 Review.

See all similar articles

Cited by

Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique.
Parkinson B, Pearson SA, Viney R. Parkinson B, et al. Eur J Health Econ. 2014 Jan;15(1):93-112. doi: 10.1007/s10198-013-0459-2. Epub 2013 Feb 24. Eur J Health Econ. 2014. PMID: 23436142
Cost of care pathways before and after appropriate and inappropriate transfers to the emergency department among nursing home residents: results from the FINE study.
Gombault-Datzenko E, Costa N, Mounié M, Tavassoli N, Mathieu C, Roussel H, Lagarrigue JM, Berard E, Rolland Y, Molinier L. Gombault-Datzenko E, et al. BMC Geriatr. 2024 Apr 19;24(1):353. doi: 10.1186/s12877-024-04946-x. BMC Geriatr. 2024. PMID: 38641801 Free PMC article. Clinical Trial.
Prospective study designs in outcomes research: the case of migraine.
Rothermich EA, Brod MI, Schonfeld WH, Rowland CR, Gomez-Mancilla B. Rothermich EA, et al. Pharmacoeconomics. 2002;20(11):715-25. doi: 10.2165/00019053-200220110-00001. Pharmacoeconomics. 2002. PMID: 12201791 Review.
Methods and Study Design for Cancer Health Economics Research: Summary of Discussions From a Breakout Session.
Henk HJ, Shih YT, Borah BJ. Henk HJ, et al. J Natl Cancer Inst Monogr. 2022 Jul 5;2022(59):95-101. doi: 10.1093/jncimonographs/lgac013. J Natl Cancer Inst Monogr. 2022. PMID: 35788374 Free PMC article.
Treatments with versus without medication for children with behavioural difficulties in clinical practice: an economic evaluation with observational data.
Kiernan CK, Dijk HH, van den Hoofdakker BJ, Hoekstra PJ, Groenman AP. Kiernan CK, et al. J Child Psychol Psychiatry. 2025 Mar;66(3):289-300. doi: 10.1111/jcpp.14057. Epub 2024 Sep 30. J Child Psychol Psychiatry. 2025. PMID: 39344292 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon